Home > Insider Trading > Filing (0001213900-25-030063)

Filing Details

Accession Number:: 0001213900-25-030063
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2025-04-08 21:35:45
Reporting Period:: 2025-03-26

Filing Date:: 2025-04-08
Accepted Time:: 2025-04-08 21:35:45
Original Submission Date:: 2025-03-28
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1979414	Neonc Technologies Holdings Inc.	NTHI	Pharmaceutical Preparations (2834)	921954864

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
2055126	(Alan) Ming-Fu Chiang	2 Dole Drive Westlake Village CA 91362		No	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2025-03-26	50,000	$0.00	390,216	No	4	A	Direct
Common Stock	Disposition	2025-03-26	5,994	$0.00	324,688	No	4	J	Indirect	By HCWG LLC
Common Stock	Acquisiton	2025-03-26	117,188	$12.00	441,876	No	4	X	Indirect	By HCWG LLC
Common Stock	Disposition	2025-03-26	56,250	$25.00	385,626	No	4	S	Indirect	By HCWG LLC
Common Stock	Disposition	2025-03-26	1,446	$19.13	384,180	No	4	S	Indirect	By HCWG LLC

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	J	Indirect	By HCWG LLC
No	4	X	Indirect	By HCWG LLC
No	4	S	Indirect	By HCWG LLC
No	4	S	Indirect	By HCWG LLC

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant (right to buy)	Disposition	2025-03-26	117,188	$0.00	117,188	$12.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2025-03-26		No	4	X	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	29,309	Indirect	By Orion Biomed Inc.
Common Stock	888,148	Indirect	By NeuCen Biomedical Co. Ltd.
Common Stock	488,196	Indirect	See footnote 8.

Footnotes

Grant of 50,000 shares of restricted common stock (the "Shares") pursuant to Issuer's 2023 Equity Incentive Plan. The Shares vest 100% seven months after the effective date of Issuer's initial listing.
Transfer of shares of common stock held by HCWG LLC ("HCWG") pursuant to agreement. The shares reported herein represent only Reporting Person's percentage interest in HCWG LLC. See also footnote 4.
Not applicable. Number of shares transferred was based on a per share value of $18.
Such shares are held by virtue of beneficial ownership of HCWG. The shares represent only Reporting Person's 37.5% interest in HCWG.
On 3/26/2025, in conjunction with Issuer's initial listing on Nasdaq, HCWG exercised a warrant to purchase 312,500 shares of Issuer's common stock at $12 per share. HCWG paid the exercise price on a cashless basis, resulting in Issuer's withholding 150,000 of the warrant shares to pay the exercise price and issuing to HCWG the remaining 162,500 shares of common stock. Number of shares reported herein as acquired and disposed of by the Reporting Person represents Reporting Person's indirect interest in HCWG.
Shares held by Orion Biotech Inc. ("Orion"). Orion is owned in part by Reporting Person, who disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
Shares held by NeuCen Biomedical Co. Ltd. ("NeuCen"). NeuCen is owned in part by Reporting Person's spouse. Reporting Person disclaims beneficial ownership of such shares except to the extent of his pecuniary interest, if any, therein.
Shares held by certain members of Reporting Person's family. Reporting Person disclaims beneficial ownership of such shares, except to the extent of his pecuniary interest, if any, therein.
Not applicable.